About Pharma Mar (OTCMKTS:PHMMF)
Pharma Mar, S.A., a biopharmaceutical company, engages in the discovery and development of marine-derived anticancer drugs in Spain and internationally. It develops and commercializes YONDELIS, a novel, multimodal, synthetically produced antitumor agent for the treatment of advanced soft tissue sarcomas as a single-agent, as well as for relapsed ovarian cancer in combination with Doxil/Caelyx. The company also has three other clinical-stage programs, including PM1183, plitidepsin, and PM184, which are under development for various types of solid and hematological cancers. In addition, it engages in molecular diagnostics; researching therapeutic applications of gene silencing; and chemical business. The company was founded in 1986 and is based in Madrid, Spain.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$200.26 million
Price / Sales3.29
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Pharma Mar (OTCMKTS:PHMMF) Frequently Asked Questions
What is Pharma Mar's stock symbol?
Pharma Mar trades on the OTCMKTS under the ticker symbol "PHMMF."
Who are some of Pharma Mar's key competitors?
Some companies that are related to Pharma Mar include Natus Medical (BABY), The Ensign Group (ENSG), LHC Group (LHCG), Dynavax Technologies (DVAX), Lexicon Pharmaceuticals (LXRX), Editas Medicine (EDIT), Dermira (DERM), Abaxis (ABAX), Lannett (LCI), DBV Technologies (DBVT), Xencor (XNCR), Genomic Health (GHDX), Heron Therapeutics (HRTX), Wave Life Sciences (WVE), Madrigal Pharmaceuticals (MDGL), Regenxbio (RGNX), Acorda Therapeutics (ACOR) and Orthofix International (OFIX).
How do I buy Pharma Mar stock?
Shares of Pharma Mar can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Pharma Mar's stock price today?
One share of Pharma Mar stock can currently be purchased for approximately $2.96.
How big of a company is Pharma Mar?
Pharma Mar has a market capitalization of $587.79 million and generates $200.26 million in revenue each year.
How can I contact Pharma Mar?
Pharma Mar's mailing address is Avda. De los Reyes 1 Pol. Ind. La Mina, Madrid U3, 28770. The company can be reached via phone at 34-91-846-6000.
MarketBeat Community Rating for Pharma Mar (PHMMF)MarketBeat's community ratings are surveys of what our community members think about Pharma Mar and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Pharma Mar (OTCMKTS:PHMMF) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for Pharma Mar (OTCMKTS:PHMMF)
No earnings announcements for this company have been tracked by MarketBeat.com
Pharma Mar (OTCMKTS:PHMMF) Earnings Estimates
Current Year EPS Consensus Estimate: $-0.07 EPS
Dividend History for Pharma Mar (OTCMKTS:PHMMF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Pharma Mar (OTCMKTS PHMMF)
No insider trades for this company have been tracked by MarketBeat.com
Pharma Mar (OTCMKTS PHMMF) News Headlines
Pharma Mar (OTCMKTS:PHMMF) SEC Filings
Financials are not available for this stock.
Pharma Mar (OTCMKTS PHMMF) Stock Chart for Monday, December, 11, 2017